HILDEN, Germany, and SEOUL, South Korea – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a collaboration in which Seegene Inc. (096530.KQ) will develop a menu of multiplex assay panels for its modular QIAsymphony RGQ MDx automation platform. The first project is to develop comprehensive panels to profile infectious diseases. Seegene’s proprietary technologies […]
SEATTLE — NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that Alessandra Cesano, M.D., Ph.D. has been named Chief Medical Officer, effective July 6, 2015. Dr. Cesano brings more than 25 years of experience in drug development, diagnostics, and cancer immunology to NanoString. She […]
OTTAWA, ON — DNA Genotek, a leading provider of sample collection kits and end-to-end services and a subsidiary of OraSure Technologies, Inc. (Nasdaq: OSUR) today announced that its OMNIgene®•GUT microbiome collection kit has received CE-IVD marking through completion of a comprehensive technical validation and self declaration under the European Directive for In Vitro Diagnostic Medical […]
NEW YORK, NY — Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has reached and finalized a settlement with Luminex Corporation (NASDAQ: LMNX) involving payment of $7.1 million to Enzo in an infringement action brought by Enzo regarding its U.S. Patents Nos. 6,992,180; 7,064,197; and 8,097,405. Today’s settlement resolving the disputes between Enzo and Luminex […]
AURORA, Colo. and BANGALORE, India — Strand Life Sciences, a global genomic profiling company that uses next generation sequencing technology to empower cancer care, today announced the appointment of Scott A. Storrer as chief executive officer. In his expanded role as now president and CEO, he will be responsible for all strategy, business expansion and […]
Stockholm — Addtech Life Science, a business area in the Addtech Group, has acquired all the shares in Fenno Medical Oy via Mediplast AB. Fenno Medical is a leading medtech actor in the Finnish market, marketing a broad range of medical equipment and consumables from world-leading suppliers. The company also sells a selected range of […]
BANGALORE and MOSCOW — ReadSense, a genomics company at nanocenter TECHNOSPARK (Troitsk), and Strand Life Sciences, the world leader in the implementation of bioinformatics in personalized medicine, have signed a cooperation memorandum. According to the memorandum, Strand and ReadSense will jointly develop affordable tests based on next-generation sequencing (NGS) for the diagnosis of genetic pathologies […]
Shenzhen, China — BGI today debuted its desktop sequencer BGISEQ-500 in China. It is the second new system based on Complete Genomics’ industry-leading sequencing technology. Earlier this month, CG’s new fully integrated “supersequencer” Revolocity™ system was previewed at ESHG. Different from Revolocity™’s scalability, BGISEQ-500 is an integrated desktop sequencing solution. It automates sample preparation, sequencing, […]
Hilden and Hellerau, Germany – QIAGEN and Biotype Diagnostics GmbH today announced that they have entered into a partnership to establish Biotype Innovation GmbH (“Biotype Innovation”). The new company will develop and commercialize molecular diagnostic workflows initially for personalized healthcare applications based on QIAGEN’s proprietary ModaPlex platform, which enables customers to detect, characterize and measure […]
San Diego, CA –– BioMed Realty Trust, Inc. (NYSE: BMR) today announced that Illumina, Inc. (NASDAQ: ILMN), a world leader in genomics focused on improving human health by unlocking the power of the genome, has signed a 20-year lease for a 155,000 square foot new and innovative scientific research building in Cambridge, England. The project […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
